Barely Significant

Excerpts

514,629 sentences

nominally significantp = 0.0230.5× alphagold
In unadjusted analyses, only mtDNA haplogroup H showed a nominally significant over-representation in the rapid pain progressors group (43.4%) compared with non-rapid progressors (39.4%) (OR = 1.179; 95%CI = 1.023–1.359; p = 0.023); however, this association did not remain significant after Bonferroni correction (q-value = 0.115).
moderately significantp = .0230.5× alphaqualifiedgold
, but not in the intervention group (G2 Adulthood Depression Indirect Effect = .004, SE = .01, 95% CI =[−.01,.02], β = .01, p = .388).The intergenerational mediating pathways from high G2childhood depressive symptoms to greater G2 adulthood depressive symptoms to more G3 emotional difficulties were moderately significant in the control group (G3 Emotional Difficulties = .05, SE = .02, 95% CI = [.01,.09], β = .06, p = .023), but not in the intervention group (G3 Emotional Difficulties = .006, SE = .01, 95% CI = [−.01, .02], β = .01, p = .450).
highly significantp = 0.0230.5× alphaqualifiedgold
In the mixed model, the choice of architecture (AUC + 0.016; p < 0.001), the level of feature extraction (AUC + 0.016; p < 0.001), and using all slices (AUC + 0.023; p < 0.001) were highly significant; using the segmentation had a lower influence (AUC + 0.011; p = 0.023), while the aggregation method was insignificant ( p = 0.774).
a trend towards significancep = 0.0230.5× alpha
Correlations of Sleep-Associated Symptoms and Nocturnal Cardiac Parasympathetic Activity While “fatigue or low energy” was reported significantly more often in SRC than in control athletes, there was only a trend towards significance in the symptom “drowsiness.” Analysis showed a positive correlation between nocturnal RMSSD during RTS and “drowsiness” (r = 0.532, p = 0.023, p adj. = 0.046), while there was no correlation between RMSSD during RTS and “fatigue or low energy” (r = 0.257, p = 0.304, p adj. = 0.304). 4.
moderately significantp = 0.0230.5× alphaqualifiedgold
A seven-day advance and a seven-day lag of SARS-CoV-2 RNA load exhibited moderately significant correlations with active cases and the combination with self-isolations among fraternities ( r s = 0.418, p = 0.023; r s = 0.478, p = 0.009; r s = 0.424, p = 0.025; r s = 0.473, p = 0.010).
showed a trendp = .0230.5× alpha
Specifically, they gave less negative evaluations of the negative scenes (this was significant for the category Distress t (11.36) = 3.64, p < .001, with trends in the same direction for scratch ( p = .034) and yawn ( p = .014)) and less positive ratings following positive scenes (which was significant for grooming t (11.36) = 3.44, p = .001 and showed a trend in play ( p = .023).
marginally significantp-value = 0.0230.5× alphagold
Using Student's t-test revealed that all values are significantly different although for the plus-strand coded promoters (in Figure 5b ) the middle-range promoter-cis values (the 301–450 range promoters paired with the 301–450 range cis elements) have only a marginally significant (p-value = 0.023) difference when compared to the 601–750 range promoters paired with the 301–450 range cis elements (i.e. middle orange bar vs. the middle purple bar in Figure 5b ).
borderline significantp = 0.0230.5× alphagold
Testing copanlisib exposure variables on the RBCM for PFS in copanlisib‐treated patients only demonstrated a statistically significant, positive ER relationship for PFS for all three time‐varying copanlisib exposure estimates ( C avg,2wk : p = 0.002; C avg,4wk : p = 0.004; C avg,8wk : p = 0.002), along with a borderline significant ( p = 0.023) relationship for copanlisib exposure expressed as time‐invariant AUC (0–168)nd (Figure 3b ), indicating that higher exposure in copanlisib‐treated patients was associated with prolonged PFS.